Royal jelly
Also called: royal bee jelly, honey bee milk, bee saliva, bee spit
Royal jelly is a viscous substance secreted by worker bees that is the essential food for queen bees and their larvae. Health Canada lists its source as a secretion of the honeybee Apis mellifera. It is consumed as a health food worldwide.
- Category
- Other
- Forms
- Fresh royal jelly, dried or powdered royal jelly and non-standardized extracts, per Health Canada's monograph; lyophilized royal jelly powder is also sold
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2019 meta-analysis (Complement Ther Med) pooled 5 randomized trials of oral royal jelly versus placebo on glycemic markers (205 participants for fasting glucose, 130 for HbA1c). [2]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHormones and reproduction3 topics
CBlood sugar and weight2 topics
CHeart and blood vessels1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood sugar markers | C | A 2019 meta-analysis of 5 placebo-controlled trials found no significant effect on fasting glucose (205 participants) or HbA1c (130 participants); the authors cite methodology issues and confounders such as diet. [2] |
| Liver enzymes and glycemic indices in adults | C | A 2023 meta-analysis of 10 RCTs found no significant overall effect on plasma liver enzymes or glycemic indices; fasting glucose fell in trials lasting 8 weeks or more and in non-healthy populations. [3] |
| Postmenopausal symptoms | B | A 2026 systematic review included 6 studies (471 postmenopausal women); pooling 2 studies (312 participants) showed improved symptoms versus placebo (SMD 0.73), rated moderate-quality evidence. [4] |
| Blood cholesterol | C | MSK reports that some limited human studies suggest improved total and LDL cholesterol in people with moderately elevated levels. [1] |
| Premenstrual symptoms | C | MSK cites a randomized, triple-blind, placebo-controlled study in medical sciences students suggesting royal jelly may improve premenstrual symptoms. [1] |
| Bone mineral density in postmenopausal women | C | MSK cites a randomized controlled study suggesting royal jelly may help preserve bone mineral density in postmenopausal women. [1] |
Main constituents: Major royal jelly proteins; MSK reports major royal jelly protein 3 was identified as the main allergen that can induce anaphylaxis [1]; Fatty acids and a sterol with weak estrogenic activity in laboratory studies, per MSK [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Health Canada's royal jelly monograph (April 24, 2026), adults: not to exceed 6 g fresh royal jelly per day (antioxidant use); 0.8–6 g fresh royal jelly per day (nutritive tonic). [5]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingHealth Canada's royal jelly monograph requires the label caution to ask a health care practitioner before use if pregnant or breastfeeding.
1 statement in the profile.
Details and sources - Interactions with medicines2 listed
Warfarin; Temozolomide
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked. The profile notes other test results.
Details and sources - FDA new dietary ingredient notifications1 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
Health Canada NNHPD Royal Jelly monograph (April 24, 2026), adults 18 years and older: not to exceed 6 g fresh royal jelly per day (antioxidant use) …
Details and sources
- MSK case reports include anaphylaxis, asthma and hemorrhagic colitis after royal jelly; references include a fatal royal jelly-induced asthma case. [1]
- Health Canada contraindication: do not use if you have a history of asthma or allergies; stop use if hypersensitivity or allergy occurs. [5]
- MSK: patients allergic to bee products should avoid royal jelly, and for this reason propolis should also be avoided. [1]
- MSK: because royal jelly has estrogenic effects, women with estrogen receptor-positive breast cancer should avoid it; prostate cancer patients should use caution because royal jelly increased testosterone in animal studies. [1]
- MSK lists anecdotal weight gain, facial rash and gastrointestinal discomfort as adverse reactions. [1]
- Health Canada requires a label caution to ask a health care practitioner before use if pregnant or breastfeeding. [5]
Interactions
| With | What happens |
|---|---|
| Warfarin | In a case report of elevated INR and subsequent bleeding, royal jelly was the only identified source of warfarin's enhanced effects (MSK). [1] |
| Temozolomide | Lab studies suggest royal jelly may increase the cytotoxic effect of temozolomide; clinical relevance has yet to be determined (MSK). [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Regulatory status
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [6]
- US: FDA's published NDI notification list has 1 entry naming royal jelly (NDI 997, lyophilized royal jelly powder, submitted 2017-02-28). [7]
- Canada: Health Canada publishes a royal jelly monograph (April 24, 2026) for licensed natural health products, with antioxidant and nutritive-tonic uses. [5]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Major royal jelly proteins (major royal jelly protein 3 identified as the main allergen that can induce anaphylaxis) Amino acids, amines and peptides (proteins) [P1]
- Fatty acids and a sterol with weak estrogenic activity in laboratory studies Fatty acids and lipids [P1]
- Antioxidant peptides, to which MSK attributes effects against oxidative stress Amino acids, amines and peptides (peptides) [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 1 entry naming royal jelly (NDI 997, lyophilized royal jelly powder, submitted 2017-02-28). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- Propolis and other bee products: MSK: patients allergic to bee products should avoid royal jelly, and for this reason propolis should also be avoided. [P1]
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P5]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- Health Canada NNHPD Royal Jelly monograph (April 24, 2026), adults 18 years and older: not to exceed 6 g fresh royal jelly per day (antioxidant use); 0.8–6 g fresh royal jelly per day (used in herbal medicine as a nutritive tonic). [P6]
Pregnancy and breastfeeding
- Health Canada's royal jelly monograph requires the label caution to ask a health care practitioner before use if pregnant or breastfeeding. [P6]
Sources for this profile
- Memorial Sloan Kettering Cancer Center. About Herbs: Royal Jelly (Last Updated July 6, 2022), 2022-07-06. mskcc.org
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. Cumulative Cross Index to IARC Monographs Volumes 1 to 142 (PDF, retrieved 2026-10-30), 2026-10-30. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606), 2026-10-30. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/29/2026), 2026-10-29. ecfr.gov
- Health Canada NNHPD. Natural health product monograph: Royal Jelly (date April 24, 2026), 2026-04-24. webprod.hc-sc.gc.ca
Sources
- Memorial Sloan Kettering Cancer Center. About Herbs: Royal Jelly (Last Updated July 6, 2022), 2022-07-06. mskcc.org
- Mahboobi S, et al. Royal jelly does not improve markers of glycemia: a systematic review and meta-analysis of randomized clinical trials. Complement Ther Med 2019;44:235-241 (PMID 31126561), 2019-06. pubmed.ncbi.nlm.nih.gov
- Bahari H, et al. The effect of royal jelly on liver enzymes and glycemic indices: a systematic review and meta-analysis of randomized clinical trials. Complement Ther Med 2023;77:102974 (PMID 37619715), 2023-10. pubmed.ncbi.nlm.nih.gov
- Ferraz SD, et al. Royal jelly for management of postmenopausal symptoms: a systematic review and meta-analysis. Menopause 2026;33(4):501-509 (PMID 41401249), 2026-04-01. pubmed.ncbi.nlm.nih.gov
- Health Canada NNHPD. Natural health product monograph: Royal Jelly (date April 24, 2026), 2026-04-24. webprod.hc-sc.gc.ca
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.